Sales decline 7.97% to Rs 6825.16 crore
Net profit of Sun Pharmaceuticals Industries declined 16.67% to Rs 1385.57 crore in the quarter ended March 2017 as against Rs 1662.79 crore during the previous quarter ended March 2016. Sales declined 7.97% to Rs 6825.16 crore in the quarter ended March 2017 as against Rs 7415.98 crore during the previous quarter ended March 2016.For the full year,net profit rose 38.67% to Rs 7846.23 crore in the year ended March 2017 as against Rs 5658.31 crore during the previous year ended March 2016. Sales rose 8.52% to Rs 30264.23 crore in the year ended March 2017 as against Rs 27888.07 crore during the previous year ended March 2016.
ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales6825.167415.98 -8 30264.2327888.07 9 OPM %22.6730.64 -33.3429.25 - PBDT1726.992374.91 -27 10312.628293.33 24 PBT1388.822086.90 -33 9047.877255.80 25 NP1385.571662.79 -17 7846.235658.31 39
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
